In a mouse PD model induced by α-synuclein preformed fibrils (PFFs), EGCG treatment decreased TNF-α and IL-6 expression, reduced pathological aggregation, increased survival of dopaminergic neurons in the substantia nigra, and improved both motor and anxiety-like behaviors (53). The gene discussed is TNF; the disease is Parkinson disease.